Compounds > perifosine
Page last updated: 2024-09-04

perifosine and 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide

perifosine has been researched along with 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide in 1 studies

Compound Research Comparison

Studies
(perifosine)		Trials
(perifosine)		Recent Studies (post-2010)
(perifosine)		Studies
(3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide)		Trials
(3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide)		Recent Studies (post-2010) (3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide)
2453114026016

Protein Interaction Comparison

ProteinTaxonomyperifosine (IC50)3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide (IC50)
Tyrosine-protein kinase ABL1Homo sapiens (human)0.7232
Breakpoint cluster region proteinHomo sapiens (human)0.267

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alekseenko, A; Barkovich, K; Hall, DR; Keseru, G; Kozakov, D; Porter, KA; Rettenmaier, J; Vajda, S; Wells, JA; Whitty, A; Xia, B; Yueh, C1

Reviews

1 review(s) available for perifosine and 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide

ArticleYear
Kinase Atlas: Druggability Analysis of Potential Allosteric Sites in Kinases.
    Journal of medicinal chemistry, 2019, 07-25, Volume: 62, Issue:14

    Topics: Allosteric Site; Animals; Databases, Protein; Drug Development; Drug Discovery; Humans; Models, Molecular; Protein Conformation; Protein Kinase Inhibitors; Protein Kinases

2019